Distribution of remikiren, a potent orally active inhibitor of human renin, in laboratory animals.

Article Details

Citation
Copy to clipboard

Richter WF, Whitby BR, Chou RC

Distribution of remikiren, a potent orally active inhibitor of human renin, in laboratory animals.

Xenobiotica. 1996 Mar;26(3):243-54.

PubMed ID
8730917 [ View in PubMed
]
Abstract

1. Whole-body autoradiography was used to compare the distribution of remikiren in the squirrel monkey, in which the compound is a potent inhibitor of renin, with the rat and the guinea-pig in which it is less active. 2. Following intravenous administration, drug-related material was rapidly and extensively taken up by the tissues of all three species. Consistent with rapid biliary elimination, high levels of radioactivity were found in the bile duct/gall bladder/intestinal contents. Of the remaining organs, the kidney consistently showed the highest concentrations of drug-related material. 3. Radio-hplc analysis of the kidney samples demonstrated that the majority of the retained material was present as intact remikiren, even at 24 h after administration. A similar degree of retention by the kidney was also found after oral dosing. 4. Uptake of remikiren by the kidney may act as a reservoir for the drug, resulting in the prolonged duration of pharmacological activity, which, despite the high plasma clearance of the drug, has previously been observed in primates.

DrugBank Data that Cites this Article

Drugs